Arthritis und Rheuma 2015; 35(06): 383-384
DOI: 10.1055/s-0037-1618394
Der besondere Fall
Schattauer GmbH

Polymyalgia rheumatica als Ursache für eine unklare persistierende CRP-Erhöhung bei einem Intensiv -therapiestation (ITS)-Patienten

A. Kleymann
1   Medizinische Klinik 3, Universitätsklinikum Dresden Carl Gustav Carus, Dresden
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2017 (online)

 

 
  • Literatur

  • 1 Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ. et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009; 61: 1454.
  • 2 Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet 2008; 372: 234.
  • 3 Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261.
  • 4 Dejaco C, Singh YP, Perel P. et al. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative. Arthritis Rheumatol 2015; 67 (10) 2569-2580.
  • 5 Seitz M. Polymyalgia rheumatica: What is the current status?. Z Rheumatol 2015; 74 (06) 507-510.
  • 6 Owen CE, Buchanan RR, Hoi A. Recent Advances in Polymyalgia Rheumatica. Intern Med J 2015. Jun 3
  • 7 Dasgupta B, Cimmino MA, Maradit-Kremers H. et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012; 71 (04) 484-492.
  • 8 Bianconi L, Buttgereit F, Carsons S. et al. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative. Arthritis Rheumatol 2015; 67 (10) 2569-2580.